TREM receptor

髓样细胞触发受体家族由多种在髓系细胞表面表达的受体组成,其中 TREM-1 和 TREM-2 为该家族中研究最为深入的两种。TREM-1 是一种免疫反应的放大器,它通过增强巨噬细胞和中性粒细胞对细菌和真菌的反应,显著促进炎症因子如 TNF-α 和 IL-1β 的释放,从而在急性炎症和感染的应答中发挥关键作用,通过调节 TREM-1 的信号可以减轻败血症的严重程度。TREM-2 则有助于调节免疫反应,通过促进巨噬细胞的抗炎和修复功能来维持组织的稳定性,尤其是在神经组织中,TREM-2 的功能与减缓神经退行性疾病如阿尔茨海默病的进展密切相关。
髓样细胞触发受体通过与其适配蛋白 DAP12 结合,启动包含酪氨酸激酶 Syk 在内的信号通路,进而激活下游的多种细胞反应,包括炎症细胞因子的产生、细胞生存信号的增强以及细胞骨架的重组。髓样细胞触发受体及其适配蛋白不仅是理解免疫调节机制的重要窗口,也为研究包括炎症性疾病和神经退行性疾病在内的多种病症提供了新的靶点[1]。

The Triggering Receptor Expressed on Myeloid cells (TREM) family consists of several receptors expressed on the surface of myeloid cells, among which TREM-1 and TREM-2 are the most extensively studied. TREM-1 acts as an amplifier of immune responses, significantly enhancing the responses of macrophages and neutrophils to bacteria and fungi, and promoting the release of inflammatory cytokines such as TNF-α and IL-1β, thus playing a crucial role in acute inflammation and infection responses. Modulating TREM-1 signaling can alleviate the severity of sepsis. TREM-2 helps regulate immune responses by promoting the anti-inflammatory and repair functions of macrophages, maintaining tissue stability, particularly in neural tissues, where the function of TREM-2 is closely associated with slowing the progression of neurodegenerative diseases like Alzheimer’s disease.
The Triggering Receptor Expressed on Myeloid cells interacts with its adaptor protein DAP12 to initiate signaling pathways, including those involving the tyrosine kinase Syk, which in turn activates a variety of downstream cellular responses, including the production of inflammatory cytokines, enhancement of cell survival signals, and reorganization of the cytoskeleton. The Triggering Receptor Expressed on Myeloid cells and their adaptor proteins are not only crucial for understanding immune regulation mechanisms but also provide new targets for the study of various diseases, including inflammatory and neurodegenerative diseases[1].

TREM receptor亚型特异性产品:TREM receptor Isoform Comparison
共 19种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Anti-Mouse TREM2 Antibody (178)

Anti-Mouse TREM2 Antibody (178) 可与小鼠 TREM-2 反应,并能在体内和体外抑制 TREM-2,推荐的同型对照为 Rat IgG2a kappa, Isotype Control (MS-B06780)。

Inhibitor
98.92%
Anti-Mouse TREM2 Antibody (178)
Anti-Mouse TREM2 Antibody (4D9)

Anti-Mouse TREM2 Antibody (4D9) 是一种靶向 TREM2 的单克隆抗体,可增强小胶质细胞信号传导,诱导可逆的小胶质细胞形态变化,将小胶质细胞转变为代谢响应状态,并增加小胶质细胞的状态多样性,可用于阿尔茨海默病的相关研究。

Inhibitor
Anti-Mouse TREM2 Antibody (4D9)
Anti-TREM2 Antibody (AL2p-58)

Anti-TREM2 Antibody (AL2p-58) 是一种靶向 TREM2 的人源化 IgG1 单克隆抗体,可用于神经炎症的研究,推荐同型对照为 Human IgG1 kappa, Isotype Control (MS-E04981)。

Inhibitor
97.43%
Anti-TREM2 Antibody (AL2p-58)
Bortezomib GMP
PS-341; LDP-341; NSC 681239

Bortezomib (GMP) (PS-341 (GMP)) 是 GMP 级别的 Bortezomib (MS-D47138),GMP 级别的小分子可用作细胞疗法中的辅助试剂,而 Bortezomib (PS-341) 是一种可逆性和选择性的蛋白酶体 (proteasome) 抑制剂,通过靶向苏氨酸残基有效抑制 20S 蛋白酶体 (Ki=0.6 nM),并可破坏细胞周期、诱导细胞凋亡、抑制核因子 NF-κB、有效抑制肿瘤相关巨噬细胞 (TAM) 中 TREM2 的表达,可用于多发性骨髓瘤的研究。

Inhibitor
Bortezomib
CEL383

CEL383 是一种靶向髓系细胞触发受体-1 (TREM1) 的全人源单克隆抗体,可通过抑制靶标信号传导降低肠道局部促炎因子水平,用于炎症性肠病的研究。

Inhibitor
CEL383
EOS006215
EOS-215

EOS006215 (EOS-215) 是一种靶向 TREM-2 的人源化单克隆抗体,可与 TREM2 配体竞争、阻止 TREM2 多聚化并阻断下游信号通路,从而抑制胞葬作用、重编程单核细胞来源巨噬细胞的转录组谱、改变代谢和免疫应答相关基因的表达并促进促炎标志物的分泌,同时降低转移负荷、延缓肿瘤生长并通过重编程肿瘤微环境克服抗 PD-1 耐药性,可用于三阴性乳腺癌和结直肠癌的相关研究。

Inhibitor
98.47%
EOS006215
IA9
human TREM-2 182-190

IA9 (human TREM-2 182-190) 是一种强效的、可透过血脑屏障的 TREM-2 抑制剂,能够减少促炎细胞因子的释放,并抑制胶 Collagen (MS-G06706) 诱导的关节炎 (CIA) 小鼠模型中的关节炎症和损伤,可用于神经炎症的 PET 成像,而 IA9 TFA 可用于类风湿性关节炎 (RA) 和神经炎症的研究。

Inhibitor
97.24%
IA9
IA9 TFA
human TREM-2 182-190 TFA

IA9 TFA(human TREM-2 182-190 TFA)是一种强效的、可透过血脑屏障的 TREM-2 抑制剂,能够减少促炎细胞因子的释放,并抑制 Collagen (MS-G06706) 诱导的关节炎 (CIA) 小鼠模型中的关节炎症和损伤,可用于神经炎症的 PET 成像以及类风湿性关节炎 (RA) 和神经炎症的研究。

Inhibitor
98.90%
IA9 TFA
Lifonebart

Lifonebart 是一种靶向 TREM2(triggering receptor expressed on myeloid cells 2)的人源化单克隆抗体,其抗体亚型为 human IgG1κ,推荐的同型对照为 Human IgG1 kappa, Isotype Control (MS-E04981)。

3056296-07-9
Inhibitor
99.9%
Lifonebart
LP17 (human)

LP17 (human) 是一种具有抗炎和抗癌作用的 TREM1 拮抗肽。

887973-05-9
Inhibitor
90.14%
LP17 (human)
LR-17
TLT-1 (94-110)

LR-17 (TLT-1 (94-110)) 是一种由 17 个氨基酸组成的肽,作为 TREM-1 抑制剂,具有抗炎作用,可减少 Lipopolysaccharides (LPS) (MS-X54539) 诱导的促炎细胞因子分泌,并可用于脓毒症的研究。

1256099-50-9
Inhibitor
97.52%
LR-17
PY159

PY159 是一种靶向 TREM1/CD354 的人源化抗体,可将免疫抑制性肿瘤内髓系细胞重编程为具有炎症性、抗肿瘤的表型,促进抗肿瘤免疫应答,上调单核细胞活化标志物,并诱导促炎细胞因子,可用于铂耐药卵巢癌、晚期实体瘤及晚期难治性实体瘤的研究。

Inhibitor
98.44%
PY159

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础